Sold out · depth page
Tirzepatide — dual agonist research (RUO)
Dual GIP / GLP-1 receptor agonist · LY3298176
Tirzepatide 10 mg · dual-agonist note
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide. This research material is not a licensed tirzepatide product.
Literature and procurement framing for Canadian laboratories while the public status is Notify when available. This page does not state a vial count or a public price.
Dual-agonist lab frame
Tirzepatide is studied as a unimolecular dual agonist at GIPR and GLP-1R. Coskun et al. cover discovery pharmacology. Later metabolic research publications identify the compound class. El et al. is the islet and GIP-receptor paper laboratories use when a readout depends on GIP receptor engagement.
Against semaglutide-class analogues, the shorthand difference is GLP-1 receptor only. Against retatrutide-class analogues, the shorthand difference is the added glucagon receptor.
Until a purchasable lot is unlocked, the public status is Notify when available. This page stays indexable and does not imply an open request for a ship-now vial.
Identity
Form
Lyophilized powder, sealed vial
Strength
10 mg lyophilized vial
Purity
≥99% HPLC (see the lot COA when a lot returns)
CAS
- Tirzepatide: 2023788-19-2
PubMed
Selected literature
- PMID 30473097 (2018) Coskun et al., Molecular Metabolism — LY3298176 dual GIP/GLP-1 agonist discovery / proof of concept
- PMID 35658024 (2022) Jastreboff et al., NEJM — SURMOUNT-1 metabolic research publication
- PMID 37277609 (2023) El et al., Nature Metabolism — tirzepatide / GIPR requirement in islet hormone-secretion research
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Bench reconstitution
When a 10 mg lot is on the bench, dissolve the lyophilized cake in bacteriostatic water to the mg/mL the protocol specifies. Solvent down the wall, swirl, do not shake. Record concentration and solvent lot. This is not a clinical dose. A 30 mg research SKU is not listed.
Diluent page: bacteriostatic water.
Storage
Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.
Certificate of analysis
Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.
Lab FAQ
Can this page be read as an in-stock offer?
No. Use Notify when available. Write request@pharmapeptidesrx.com with the compound and the 10 mg strength for a restock note. This page does not publish prices or banking details. Invoices go out from request@ only.
In this library
Sold out
Notify on restock
This lot is sold out. Write request@pharmapeptidesrx.com and we email you when it is back.